Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jingdong Zhou"'
Autor:
Weilin Wang, Jingdong Zhou, Xuetao Kong, Yixuan Wang, Qixian Wu, Xiaoqing Gong, Jingye Tai, Yingxin Pan, Hongyuan Huang, Zhen Zhao, Mei Jiang, Jie Liu
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background The safety and efficacy of vaccination against coronavirus disease 2019 (COVID-19) in patients with lymphangioleiomyomatosis (LAM) is still unclear. This study investigates COVID-19 vaccine hesitancy, vaccine safety and efficacy,
Externí odkaz:
https://doaj.org/article/3ef082813da140b49b15d504c577c520
Autor:
Qi Zhao, Yun Wang, Di Yu, Jia-Yan Leng, Yangjing Zhao, Mingqiang Chu, Zijun Xu, Hao Ding, Jingdong Zhou, Tingjuan Zhang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Dysregulation of inhibitor of differentiation/DNA binding (ID) genes is linked to cancer growth, angiogenesis, invasiveness, metastasis and patient survival. Nevertheless, few investigations have systematically determined the expr
Externí odkaz:
https://doaj.org/article/05e9fac2599640ddb82340e1ad7f0d1d
Autor:
Runbi Ji, Xu Zhang, Hongbing Gu, Jichun Ma, Xiangmei Wen, Jingdong Zhou, Hui Qian, Wenrong Xu, Jun Qian, Jiang Lin
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 18, Iss , Pp 320-331 (2019)
Chemoresistance is one of the causes associated with poor prognosis in gastric cancer. MicroRNAs (miRNAs) are important regulators of chemoresistance. Exosome-mediated delivery of anti-cancer molecules and drugs have emerged as a new approach for can
Externí odkaz:
https://doaj.org/article/bcd173e3c8354c6ebbdec30df9758432
Publikováno v:
Cancer Biomarkers. 29:387-397
BACKGROUND: The runt-related transcription factor family (RUNXs) including RUNX1, RUNX2, and RUNX3 are key transcriptional regulators in normal hematopoiesis. RUNXs dysregulations caused by aberrant expression or mutation are frequently seen in vario
Publikováno v:
Aging (Albany NY)
TET family members (TETs) encode proteins that represent crucial factors in the active DNA demethylation pathway. Evidence has proved that TET2 mutation is associated with leukemogenesis, drug response, and prognosis in acute myeloid leukemia (AML).
Autor:
Jingdong Zhou
Publikováno v:
SECURITY AND PRIVACY. 6
Publikováno v:
Microgravity Science and Technology. 34
Publikováno v:
Cancers. 14:4406
Mutations of spliceosome genes have been frequently identified in myeloid malignancies with the large-scale application of advanced sequencing technology. U2 small nuclear RNA auxiliary factor 1 (U2AF1), an essential component of U2AF heterodimer, pl
Publikováno v:
Cancers. 14:2560
As the first identified selenoprotein, glutathione peroxidase 1 (GPX1) is a widely and abundantly expressed antioxidant enzyme. GPX1 utilizes glutathione as a substrate to catalyze hydrogen peroxide, lipid peroxide, and peroxynitrite, thereby reducin
Publikováno v:
ISIJ International. 57:706-712